Antimicrobial Agents and Chemotherapy · 1996 · 85 citations · 13 references
MedicinePharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyPharmacodynamicsAntibacterial PharmacologyAntibacterial PharmacotherapyTuberculosis PharmacotherapyBactericidal AgentsCo-use Of Other DrugsConcentration-dependent ActivityMycobacterium Tuberculosis InfectionSynergistic Drug Combinations
The bactericidal actions of ofloxacin and sulbactam-ampicillin, alone and in combination with rifampin and isoniazid, on exponential-phase and stationary-phase cultures of a drug-susceptible isolate of Mycobacterium tuberculosis were studied in vitro. In exponential-phase cultures, all drugs were bactericidal, with the higher concentrations of ofloxacin (5 micrograms/ml) and sulbactam-ampicillin (15 micrograms of ampicillin per ml) being as bactericidal as 1 microgram of isoniazid per ml or 1 microgram of rifampin per ml. In two-drug combinations, both drugs increased the levels of activity of isoniazid and rifampin and were almost as bactericidal as isoniazid-rifampin; they also appeared to increase the level of activity of isoniazid-rifampin in three-drug combinations. In contrast, ofloxacin and sulbactam-ampicillin had little bactericidal activity against stationary-phase cultures and were less active than isoniazid or rifampin alone. Furthermore, in two-drug or three-drug combinations, they did not increase the level of activity of isoniazid, rifampin, or isoniazid-rifampin. These findings suggest that ofloxacin and sulbactam-ampicillin are likely to be most useful in the early stages of treatment and in preventing the emergence of resistance to other drugs but are unlikely to be effective as sterilizing drugs helping to kill persisting lesional bacilli.
13
The action of antituberculosis drugs in short-course chemotherapy
D.A. Mitchison · Tubercle · 1985 · 512 citations
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Amina Jindani, V R Aber, Eric Edwards et al. · PubMed · 1980 · 498 citations
Amoxicillin-Clavulanic Acid for Treating Drug-Resistant Mycobacterium tuberculosis
Jeffrey P. Nadler, Judith Berger, Jill A. Nord et al. · CHEST Journal · 1991 · 111 citations